C9F-13091-37162
4 vaccinations
3 coded responses
27 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 605 / IL
- Registered
- 2021-04-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Dose 1 — Moderna
-
2021-04-16
Dose 2 — Moderna
-
2021-04-17
Registered in v-safe
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-07-16
-
2021-10-15
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2021-10-15
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-20
-
2021-10-31
Dose 3 — Moderna
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · HeadacheFree text: Very swollen lymph node near collarboneMedDRA releases: 2024-11 · check-in free text available
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-11-04
- 2021-11-05
- 2021-11-07
- 2021-11-16
- 2021-11-21
- 2021-11-30
- 2021-12-05
- 2022-01-30
-
2022-04-20
Dose 4 — Moderna
- 2022-05-01
-
2022-07-20
Survey response — 3 months, dose 4MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tested positive for covid-19MedDRA releases: 2024-11 · check-in free text available
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Moderna | |
| 2 | 2021-04-16 | Moderna | |
| 3 | 2021-10-31 | Moderna | No |
| 4 | 2022-04-20 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-15 | Unsuccessful |
Free text
Release 10 — 6 months, dose 2
Symptoms: Miscarriage
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Very swollen lymph node near collarbone
Release 12 — 3 months, dose 4
Symptoms: Tested positive for covid-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release